New hybrid 'NOSH aspirin' as possible anti-cancer drug

Scientists have combined two new "designer" forms of aspirin into a hybrid substance that appears more effective than either of its forebears in controlling the growth of several forms of cancer in laboratory tests. Their ...

page 1 from 5